+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Home Infusion Therapy - Global Strategic Business Report

  • PDF Icon

    Report

  • 92 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302517
The global market for Home Infusion Therapy was valued at US$43.1 Billion in 2024 and is projected to reach US$63.5 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Home Infusion Therapy Market - Key Trends and Drivers Summarized

Why Is Home Infusion Therapy a Game-Changer for Healthcare Delivery?

Home infusion therapy is transforming healthcare delivery by enabling patients to receive intravenous (IV) treatments, such as antibiotics, nutrition, or chemotherapy, in the comfort of their homes. This form of care is particularly beneficial for individuals with chronic conditions or infections that require long-term treatment but do not necessitate hospitalization. By receiving therapy at home, patients can maintain a higher quality of life, avoid hospital-acquired infections, and reduce healthcare costs. As healthcare systems shift toward patient-centric models of care, home infusion therapy has gained traction, offering a convenient and effective alternative to in-hospital treatments for conditions like cancer, immune deficiencies, and severe infections.

How Are Technological Innovations Shaping the Home Infusion Therapy Market?

Technological advancements in infusion devices, remote monitoring, and telehealth are significantly enhancing the home infusion therapy market. Infusion pumps have become more compact, portable, and user-friendly, allowing patients to manage their treatments with minimal assistance. Remote monitoring technologies enable healthcare providers to track patient progress, manage dosages, and detect complications in real-time, ensuring that treatments are administered safely and effectively. The integration of telehealth platforms has further improved patient care, enabling virtual consultations and providing medical guidance from healthcare professionals. These innovations are making home infusion therapy more accessible and reducing the risks associated with long-term IV therapy.

How Do Market Segments Define the Growth of the Home Infusion Therapy Industry?

Product types include infusion pumps, intravenous sets, needleless connectors, and catheters, with infusion pumps holding the largest market share due to their central role in administering precise dosages. Therapy types include antibiotic therapy, chemotherapy, hydration therapy, and parenteral nutrition, with antibiotic therapy being the most commonly administered at home. End-users of home infusion therapy include hospitals, specialty pharmacies, and home healthcare providers, with home healthcare agencies and specialty pharmacies playing an increasingly important role in delivering and managing home-based treatments.

What Factors Are Driving the Growth in the Home Infusion Therapy Market?

The growth in the home infusion therapy market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in infusion technology, and the rising demand for home-based healthcare services. As the global population ages, the incidence of chronic conditions such as cancer, diabetes, and immune disorders has increased, driving demand for long-term infusion therapy that can be administered outside of hospital settings. Technological advancements in portable infusion devices and remote monitoring systems have made it safer and more convenient for patients to receive infusion therapy at home. Additionally, the growing emphasis on reducing healthcare costs and improving patient outcomes is fueling the expansion of home infusion therapy services, as more patients seek care that enhances their quality of life while minimizing hospital stays.

Report Scope

The report analyzes the Home Infusion Therapy market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Product Type (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors); Application (Anti-Infective, Endocrinology, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Chemotherapy, Other Applications).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Infusion Pumps segment, which is expected to reach US$29.4 Billion by 2030 with a CAGR of a 5.6%. The Intravenous Sets segment is also set to grow at 6.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $11.2 Billion in 2024, and China, forecasted to grow at an impressive 10% CAGR to reach $15 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Baxter International, Inc., Becton, Dickinson and Company (BD), Braun Melsungen AG, BriovaRx Infusion Services, Caesarea Medical Electronics and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Home Infusion Therapy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Home Infusion Therapy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Home Infusion Therapy Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 36 major companies featured in this Home Infusion Therapy market report include:

  • Baxter International, Inc.
  • Becton, Dickinson and Company (BD)
  • Braun Melsungen AG
  • BriovaRx Infusion Services
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Cosmed
  • Eli Lilly and Company
  • Eitan Medical
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • Lincare Holdings, Inc.
  • Moong, Inc.
  • Smiths Medical
  • Terumo Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Home Infusion Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Diseases and Aging Population Propels Growth in Home Infusion Therapy
  • Technological Advancements in Infusion Pumps and Devices Drive Market Innovation
  • Increasing Preference for In-Home Healthcare Services Strengthens the Business Case for Home Infusion
  • Advances in Telemedicine and Remote Monitoring Technologies Propel Adoption of Home Infusion Therapy
  • Growing Adoption of Specialty Medications for Cancer, Diabetes, and Immune Disorders Spurs Demand
  • Rising Focus on Patient Comfort and Convenience Strengthens the Case for Home Infusion Services
  • Expansion of Home Healthcare Providers and Services Fuels Growth in Home Infusion Therapy
  • Growing Demand for Antibiotic and Pain Management Infusions Expands Product Offerings
  • Rising Focus on Reducing Hospital Readmissions Strengthens the Need for Home Infusion Solutions
  • Increased Awareness of the Benefits of Home Infusion Therapy Drives Adoption Among Patients and Providers
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Home Infusion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Home Infusion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Home Infusion Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Intravenous Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Intravenous Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Intravenous Sets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for IV Cannulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for IV Cannulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for IV Cannulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Needleless Connectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for Needleless Connectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 15: World 15-Year Perspective for Needleless Connectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 17: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 18: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 23: World Historic Review for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 24: World 15-Year Perspective for Anti-Infective by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 26: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 27: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Enteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 29: World Historic Review for Enteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 30: World 15-Year Perspective for Enteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 32: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 33: World 15-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 35: World Historic Review for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 36: World 15-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 37: World Home Infusion Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Home Infusion Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Baxter International, Inc.
  • Becton, Dickinson and Company (BD)
  • Braun Melsungen AG
  • BriovaRx Infusion Services
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Cosmed
  • Eli Lilly and Company
  • Eitan Medical
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • Lincare Holdings, Inc.
  • Moong, Inc.
  • Smiths Medical
  • Terumo Corporation

Table Information